Home » Healthcare » Australia and New Zealand Radiography Products Market

Australia and New Zealand Radiography Products Market By Type (Digital Radiography (DR), Computed Radiography (CR), Analog Radiography); By Application (Medical Radiography, Industrial Radiography); By End-user (Hospitals and Clinics, Diagnostic Centers, Industrial Manufacturing Units, Others); By Technology (Direct Radiography, Indirect Radiography); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $1999

Published: | Report ID: 38403 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
Australia and New Zealand Radiography Products Market Size 2023  USD 78.61 Million
Australia and New Zealand Radiography Products Market, CAGR  5.23%
Australia and New Zealand Radiography Products Market Size 2032  USD 124.38 Million

Market Overview

The Australia and New Zealand radiography products market is projected to grow from USD 78.61 million in 2023 to USD 124.38 million by 2032, at a compound annual growth rate (CAGR) of 5.23%.

The Australia and New Zealand radiography products market is driven by technological advancements in imaging systems, increasing prevalence of chronic diseases, and rising demand for early diagnostic tools. Government initiatives to improve healthcare infrastructure and a growing aging population further fuel market growth. Trends include the adoption of digital radiography over traditional methods, integration of artificial intelligence for enhanced imaging accuracy, and increased investment in research and development. Additionally, the shift towards minimally invasive procedures and the expansion of telemedicine services are notable trends influencing the market dynamics.

In the Australia and New Zealand radiography products market, geographical analysis reveals Australia as the dominant player, owing to its advanced healthcare infrastructure and higher healthcare expenditure. New Zealand also shows significant growth potential due to increasing healthcare investments and adoption of new technologies. Key players in this market include Koninklijke Philips NV, Siemens Healthineers, GE Healthcare, and Canon Medical Systems. These companies are focusing on innovation, strategic partnerships, and expansion to strengthen their market presence. Local players and emerging startups are also contributing to the market by introducing cost-effective and advanced radiography solutions.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Drivers

Increasing Aging Population

Australia and New Zealand, like many other developed countries, have aging populations. For instance, in Australia, the proportion of the population aged 65 years and over has been increasing steadily, reaching 15.9% in 2021. This trend is expected to continue, with projections indicating that by 2057, this age group will constitute 22% of the population. Similarly, in New Zealand, the number of people aged 65 and over is projected to double to more than 1.2 million by 2038. As a result of this aging demographic, the prevalence of chronic conditions has risen. For example, the incidence of osteoporosis in Australia is estimated to affect 4.74% of the population, with higher rates among those aged 65 and over. Arthritis is another common condition, affecting around 3.6 million Australians, which is projected to increase to 5.4 million by 2030. Cardiovascular diseases remain a leading cause of death, with 1 in 6 Australians or approximately 4.2 million living with one or more heart or vascular conditions. Consequently, healthcare providers in these regions are increasingly investing in advanced radiography equipment to cater to the needs of their aging patients.

Rising Burden of Chronic Diseases

The rising prevalence of chronic diseases such as cancer, heart disease, and arthritis is another major driver of the radiography products market in Australia and New Zealand. For instance, in Australia, nearly half of the population (49.9%) had at least one chronic condition in 2022. Mental and behavioural conditions (26.1%), back problems (15.7%), and arthritis (14.5%) were the most common chronic conditions reported. The prevalence of chronic diseases such as heart disease, stroke, and vascular disease was 5.2%, while osteoporosis affected 3.4% of the population. These conditions often require radiographic imaging for diagnosis and management. In New Zealand, chronic diseases are also a significant health challenge, with conditions like cancer, heart disease, and arthritis driving the need for advanced radiography. For example, cancer is one of the leading causes of death in New Zealand, and early detection through radiography can significantly improve treatment outcomes. The demand for radiography products is further amplified by the fact that many people with chronic conditions have more than one condition at the same time (multimorbidity). In Australia, for instance, of those who had Chronic Obstructive Pulmonary Disease (COPD) in 2022, almost nine in ten (86.6%) had another condition. This highlights the complexity of managing chronic diseases and the vital role radiography plays in providing comprehensive care. The increasing burden of these diseases necessitates continuous advancements and availability of radiographic technology to ensure timely and accurate diagnosis and treatment.

Technological Advancements

Technological advancements in the field of radiography are constantly evolving, introducing innovative solutions that enhance diagnostic capabilities. For instance, recent advancements in radiography technology have introduced Artificial Intelligence (AI) and Machine Learning (ML) algorithms that can aid radiologists by automating tedious and time-consuming tasks, such as measuring the size of lung cancer nodules during follow-up CT scans. This automation not only improves diagnostic accuracy but also significantly reduces the workload on radiologists, potentially addressing issues like physician burnout and staff shortages. Another example is the shift towards web-based enterprise imaging systems, which are replacing traditional PACS. These systems eliminate silos between modalities and allow clinicians to access images and reports from anywhere, without the need for specific workstations. The integration of AI and advanced imaging tools into these systems, along with seamless interfacing with Electronic Medical Records (EMRs), enables greater access to images and reports across health systems and facilitates patient data sharing. Moreover, the move to off-site cloud storage for archiving images and patient data is becoming increasingly popular. Companies like Google Health and Amazon offer 24/7/365 monitoring by cybersecurity teams and the ability to upscale server storage without the need for additional hardware. This trend is driven by the desire for hospitals to outsource storage more economically and efficiently, allowing them to quickly scale storage to their needs.

Government Funding

The governments of Australia and New Zealand provide substantial funding for healthcare, including radiology services. This government support ensures that hospitals and healthcare providers have access to the latest radiography products, facilitating high-quality patient care. Government funding not only supports the procurement of advanced imaging equipment but also aids in the implementation of training programs for medical professionals. These initiatives help maintain a high standard of radiographic services, which in turn drives the market for radiography products. Enhanced funding and supportive healthcare policies create a conducive environment for market growth, ensuring that the latest technologies are available to meet the growing healthcare demands.

Market Trends

Shift Towards Digital Radiography and Growth of Advanced Imaging Modalities

The radiography products market in Australia and New Zealand is experiencing a significant shift towards digital radiography (DR). Traditional film-based X-rays are rapidly being replaced by DR systems due to their numerous advantages, such as superior image quality, reduced radiation exposure, and quicker turnaround times.  The adoption of Picture Archiving and Communication Systems (PACS) is also on the rise, with New Zealand achieving an EHR adoption rate of 97%, which includes PACS integration. This includes growth in demand for CT scanners, MRI, and ultrasound systems. For example, CT and MRI are essential for detecting complex pathologies, with CT scanners expected to register the highest growth due to their effective diagnosis of tumors and respiratory diseases. Ultrasound is also gaining popularity, particularly in obstetrics, cardiology, and emergency medicine, due to its real-time imaging capabilities and non-invasive nature. The rising incidence of chronic diseases such as cancer and cardiovascular diseases is driving the need for precise diagnostic tools. In 2020, there were an estimated 200,021 new cancer cases diagnosed and 48,236 cancer deaths in Australia.

Additionally, an estimated 571,000 Australians aged 18 and over had Coronary heart disease (CHD) in 2020-21. These statistics highlight the critical role of advanced imaging technologies in diagnosing and managing chronic diseases, contributing to the significant market growth in the region.

Focus on Reducing Radiation Dose and Integration of AI and Tele-radiology

There is an increasing focus on reducing radiation doses in radiographic procedures due to growing concerns about the long-term health risks associated with radiation exposure. For instance, recent innovations in radiography have led to the development of dose reduction software that can significantly decrease the radiation dose required for imaging. Techniques such as adjusting the frame rate of fluoroscopy to ≤3/sec can reduce the radiation dose by up to a factor of 8, depending on the dose/pulse compensation algorithms of the imaging system. Advanced image processing algorithms are also being employed to enhance image clarity while using lower radiation dosages, which is particularly important for vulnerable populations such as children and pregnant women. Low-dose imaging protocols are increasingly becoming the norm in clinical practice. For example, reducing mAs by 50% of the standard dose in plain radiography of the full-length lower extremity and full spine does not affect the clinical validity and the image quality. This demonstrates that it is possible to maintain high-quality imaging standards while significantly reducing radiation exposure to patients. Furthermore, the adoption of new technologies like X-ray beam energy optimization, added filtration, and aggressive collimation are contributing to dose reduction. These techniques not only improve patient safety but also ensure compliance with regulatory guidelines that mandate lower radiation doses in medical imaging.

Market Challenges Analysis

Reimbursement Challenges and High Cost of Advanced Imaging Equipment

The Australia and New Zealand radiography products market faces significant challenges related to reimbursement and the high cost of advanced imaging equipment. Medicare, the government health insurance scheme in both countries, has historically lagged in updating reimbursement rates for radiology services. This discrepancy often results in healthcare providers not being fully compensated for the cost of acquiring and maintaining radiography products. Consequently, hospitals and clinics may be discouraged from investing in new, state-of-the-art equipment, which can hinder the adoption of advanced diagnostic technologies. This financial strain is particularly pronounced in rural and regional areas, where healthcare budgets are often more constrained. Additionally, the high cost of advanced imaging modalities, such as CT scanners and MRIs, presents a substantial barrier to entry. These sophisticated machines require significant capital investment, making it difficult for smaller healthcare facilities to afford them. As a result, patients in less urbanized areas may have limited access to cutting-edge diagnostic tools, potentially leading to disparities in healthcare quality and outcomes.

Skilled Workforce Shortage and Stringent Regulatory Environment

Another critical challenge in the radiography market of Australia and New Zealand is the shortage of skilled radiologists and radiographers, compounded by a stringent regulatory environment. The demand for qualified professionals in radiology outstrips supply, particularly in remote regions, leading to delays in diagnosis and treatment. This shortage can cause increased workload for existing staff, potentially impacting the quality of patient care and increasing burnout among healthcare professionals. Furthermore, the regulatory environment for radiography products in these countries is rigorous, with stringent requirements for safety and efficacy. While these regulations are essential for ensuring patient safety and maintaining high standards, they can also slow down the process of bringing new products to market. The lengthy approval process can deter innovation and delay the availability of advanced radiographic technologies to healthcare providers and patients.

Market Segmentation Analysis:

By Type:

The Australia and New Zealand radiography products market is segmented by type into Digital Radiography (DR), Computed Radiography (CR), and Analog Radiography. Digital Radiography (DR) is the leading segment, driven by its superior image quality, lower radiation doses, and faster processing times compared to traditional methods. The increasing adoption of DR systems is also supported by advancements in digital imaging technologies and the integration of AI for enhanced diagnostic accuracy. Computed Radiography (CR) still holds a significant market share, particularly in healthcare facilities transitioning from analog to digital systems, as it offers a cost-effective interim solution. However, Analog Radiography, the oldest technology, is witnessing a steady decline due to its limitations in image quality, higher radiation exposure, and slower processing speeds. The shift towards more efficient and accurate imaging solutions is expected to continue driving the dominance of DR in the market.

By Application:

Based on application, the radiography products market in Australia and New Zealand is categorized into Medical Radiography and Industrial Radiography. Medical Radiography is the predominant segment, fueled by the rising prevalence of chronic diseases, an aging population, and the growing demand for early and accurate diagnostic tools. Hospitals, clinics, and diagnostic centers are increasingly investing in advanced radiography systems to enhance patient care and diagnostic precision. Within this segment, applications range from routine chest X-rays to complex diagnostic imaging procedures like mammography and orthopedic assessments. Industrial Radiography, though smaller in comparison, plays a crucial role in non-destructive testing (NDT) across various industries such as construction, aerospace, and manufacturing. This application involves the use of radiographic techniques to inspect the integrity of materials and components without causing damage. The demand for industrial radiography is driven by stringent safety and quality standards in industrial operations, ensuring the continued relevance of this segment.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Segments:

Based on Type

  • Digital Radiography (DR)
  • Computed Radiography (CR)
  • Analog Radiography

Based on Application

  • Medical Radiography
  • Industrial Radiography

Based on End-user

  • Hospitals and Clinics
  • Diagnostic Centers
  • Industrial Manufacturing Units
  • Others

Based on Technology

  • Direct Radiography
  • Indirect Radiography

Based on the Geography:

  • Australia
  • New Zealand

Regional Analysis

Australia

Australia holds the larger market share in the region, accounting for approximately 70% of the total radiography products market. The country’s well-established healthcare system, coupled with a strong emphasis on adopting advanced medical imaging technologies, has fueled the demand for radiography products. Major cities like Sydney, Melbourne, and Brisbane, with their concentrated healthcare facilities and research institutions, have played a significant role in driving market growth. Furthermore, the Australian government’s initiatives to improve access to quality healthcare services have contributed to the adoption of radiography products across the country.

New Zealand

New Zealand, on the other hand, holds a market share of around 30% in the region. Despite its smaller population and healthcare infrastructure compared to Australia, New Zealand has witnessed a steady growth in the adoption of radiography products. The country’s focus on providing accessible and efficient healthcare services, particularly in rural areas, has driven the need for reliable and advanced radiography equipment. Additionally, the presence of leading healthcare providers and the increasing emphasis on early detection and preventive care have contributed to the market’s growth in New Zealand.

Key Player Analysis

  1. Siemens Healthineers
  2. Koninklijke Philips NV
  3. GE Healthcare
  4. Carestream Health
  5. Canon Australia Pty Ltd
  6. Fujifilm Holdings Corporation

Competitive Analysis

In the Australia and New Zealand radiography products market, Siemens Healthineers, Koninklijke Philips NV, and GE Healthcare are leading players, distinguished by their extensive product portfolios and innovative solutions in digital and computed radiography. Siemens Healthineers leverages advanced imaging technologies and AI integration to offer superior diagnostic accuracy and efficiency. Koninklijke Philips NV is renowned for its cutting-edge digital radiography systems, emphasizing patient safety through reduced radiation doses and enhanced image quality. GE Healthcare stands out with its comprehensive range of radiographic equipment, focusing on improving clinical outcomes through advanced imaging solutions. Carestream Health, Canon Australia Pty Ltd, and Fujifilm Holdings Corporation also hold significant market positions. Carestream Health is noted for its cost-effective and high-performance imaging systems, catering to both medical and industrial applications.

Recent Developments

In May 2023, TRG Imaging , the radiology arm of Canopy Healthcare opened a new Canning Road Clinic in Hawke Bay, New Zealand, which accommodates the Siemens 3T MRI (magnetic resonance imaging) machine.

Market Concentration & Characteristics

The Australia and New Zealand radiography products market is characterized by a moderate to high level of market concentration, with a few key players dominating the landscape. Major companies such as Siemens Healthineers, Koninklijke Philips NV, GE Healthcare, Carestream Health, Canon Australia Pty Ltd, and Fujifilm Holdings Corporation hold substantial market shares due to their extensive product lines, technological innovation, and strong brand recognition. These players continuously invest in research and development to introduce advanced radiography solutions that offer improved diagnostic capabilities, reduced radiation exposure, and enhanced operational efficiency. The market also features a blend of established multinational corporations and emerging local companies, contributing to competitive dynamics. The concentration of market power among leading firms underscores the importance of strategic partnerships, innovation, and customer-centric solutions to maintain competitive advantage and drive market growth. This structure facilitates high standards of quality and innovation while posing challenges for smaller entrants aiming to gain significant market traction.

Report Coverage

The research report offers an in-depth analysis based on Type, Application, End-user, Technology and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. Increased adoption of digital radiography systems due to their superior image quality and efficiency.
  2. Growing integration of artificial intelligence to enhance diagnostic accuracy and streamline workflows.
  3. Rising demand for advanced imaging modalities like CT and MRI to cater to complex diagnostic needs.
  4. Expansion of tele-radiology services to improve access to radiographic interpretation in remote areas.
  5. Continued government funding to support healthcare infrastructure and procurement of advanced imaging technologies.
  6. Focus on reducing radiation doses to address safety concerns and comply with regulatory standards.
  7. Increased investment in research and development to drive innovation in radiography products.
  8. Growing awareness of the benefits of early diagnosis and preventative healthcare fueling market growth.
  9. Expansion of radiography applications beyond medical into industrial sectors for non-destructive testing.
  10. Enhanced data security measures to protect patient information in an increasingly digital radiography environment.

CHAPTER NO. 1 : INTRODUCTION 15
1.1.1. Report Description 15
Purpose of the Report 15
USP & Key Offerings 15
1.1.2. Key Benefits for Stakeholders 15
1.1.3. Target Audience 16
1.1.4. Report Scope 16
CHAPTER NO. 2 : EXECUTIVE SUMMARY 17
2.1. Australia and New Zealand Radiography Products Market Snapshot 17
2.1.1. Australia and New Zealand Radiography Products Market, Volume (Units) & Revenue (USD Million) 2018 – 2032 19
2.2. Insights from Primary Respondents 20
CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 21
3.1. Russia-Ukraine and Israel-Palestine War Impacts 21
CHAPTER NO. 4 : AUSTRALIA AND NEW ZEALAND RADIOGRAPHY PRODUCTS MARKET – INDUSTRY ANALYSIS 22
4.1. Introduction 22
4.2. Market Drivers 23
4.2.1. Driving Factor 1 Analysis 23
4.2.2. Driving Factor 2 Analysis 24
4.3. Market Restraints 25
4.3.1. Restraining Factor Analysis 25
4.4. Market Opportunities 26
4.4.1. Market Opportunity Analysis 26
4.5. Porter’s Five Forces Analysis 27
CHAPTER NO. 5 : ANALYSIS COMPETITIVE LANDSCAPE 28
5.1. Company Market Share Analysis – 2023 28
5.1.1. Australia and New Zealand Radiography Products Market: Company Market Share, by Revenue, 2023 28
5.1.2. Australia and New Zealand Radiography Products Market: Company Market Share, by Revenue, 2023 29
5.1.3. Australia and New Zealand Radiography Products Market: Top 6 Company Market Share, by Revenue, 2023 29
5.1.4. Australia and New Zealand Radiography Products Market: Top 3 Company Market Share, by Revenue, 2023 29
5.2. Australia and New Zealand Radiography Products Market Company Volume Market Share, 2023 31
5.3. Australia and New Zealand Radiography Products Market Company Revenue Market Share, 2023 32
5.4. Company Assessment Metrics, 2023 33
5.4.1. Stars 33
5.4.2. Emerging Leaders 33
5.4.3. Pervasive Players 33
5.4.4. Participants 33
5.5. Start-ups /SMEs Assessment Metrics, 2023 33
5.5.1. Progressive Companies 33
5.5.2. Responsive Companies 33
5.5.3. Dynamic Companies 33
5.5.4. Starting Blocks 33
5.6. Strategic Developments 34
5.6.1. Acquisitions & Mergers 34
New Product Launch 34
Australia and New Zealand Expansion 34
5.7. Key Players Product Matrix 35
CHAPTER NO. 6 : PESTEL & ADJACENT MARKET ANALYSIS 36
6.1. PESTEL 36
6.1.1. Political Factors 36
6.1.2. Economic Factors 36
6.1.3. Social Factors 36
6.1.4. Technological Factors 36
6.1.5. Environmental Factors 36
6.1.6. Legal Factors 36
6.2. Adjacent Market Analysis 36
CHAPTER NO. 7 : AUSTRALIA AND NEW ZEALAND RADIOGRAPHY PRODUCTS MARKET – BY TYPE OF RADIOGRAPHY SYSTEMS SEGMENT ANALYSIS 37
7.1. Australia and New Zealand Radiography Products Market Overview, by Type of Radiography Systems Segment 37
7.1.1. Australia and New Zealand Radiography Products Market Revenue Share, By Type of Radiography Systems, 2023 & 2032 38
7.1.2. Australia and New Zealand Radiography Products Market Attractiveness Analysis, By Type of Radiography Systems 39
7.1.3. Incremental Revenue Growth Opportunity, by Type of Radiography Systems, 2024 – 2032 39
7.1.4. Australia and New Zealand Radiography Products Market Revenue, By Type of Radiography Systems, 2018, 2023, 2027 & 2032 40
7.2. Digital Radiography (DR) 41
7.3. Computed Radiography (CR) 42
7.4. Analog Radiography 43
CHAPTER NO. 8 : AUSTRALIA AND NEW ZEALAND RADIOGRAPHY PRODUCTS MARKET – BY APPLICATION SEGMENT ANALYSIS 44
8.1. Australia and New Zealand Radiography Products Market Overview, by Application Segment 44
8.1.1. Australia and New Zealand Radiography Products Market Revenue Share, By Application, 2023 & 2032 45
8.1.2. Australia and New Zealand Radiography Products Market Attractiveness Analysis, By Application 46
8.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 46
8.1.4. Australia and New Zealand Radiography Products Market Revenue, By Application, 2018, 2023, 2027 & 2032 47
8.2. Medical Radiography 48
8.3. Industrial Radiography 49
CHAPTER NO. 9 : AUSTRALIA AND NEW ZEALAND RADIOGRAPHY PRODUCTS MARKET – BY END-USER SEGMENT ANALYSIS 50
9.1. Australia and New Zealand Radiography Products Market Overview, by End-user Segment 50
9.1.1. Australia and New Zealand Radiography Products Market Revenue Share, By End-user, 2023 & 2032 51
9.1.2. Australia and New Zealand Radiography Products Market Attractiveness Analysis, By End-user 52
9.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 52
9.1.4. Australia and New Zealand Radiography Products Market Revenue, By End-user, 2018, 2023, 2027 & 2032 53
9.2. Hospitals and Clinics 54
9.3. Diagnostic Centers 55
9.4. Industrial Manufacturing Units 56
9.5. Others 57
CHAPTER NO. 10 : AUSTRALIA AND NEW ZEALAND RADIOGRAPHY PRODUCTS MARKET – BY TECHNOLOGY SEGMENT ANALYSIS 58
10.1. Australia and New Zealand Radiography Products Market Overview, by Technology Segment 58
10.1.1. Australia and New Zealand Radiography Products Market Revenue Share, By Technology, 2023 & 2032 59
10.1.2. Australia and New Zealand Radiography Products Market Attractiveness Analysis, By Technology 60
10.1.3. Incremental Revenue Growth Opportunity, by Technology, 2024 – 2032 60
10.1.4. Australia and New Zealand Radiography Products Market Revenue, By Technology, 2018, 2023, 2027 & 2032 61
10.2. Direct Radiography 62
10.3. Indirect Radiography 63
CHAPTER NO. 11 : COMPANY PROFILES 64
11.1. Siemens Healthineers 64
11.1.1. Company Overview 64
11.1.2. Product Portfolio 64
11.1.3. Swot Analysis 64
11.1.4. Business Strategy 64
11.1.5. Financial Overview 65
11.2. Koninklijke Philips NV 66
11.3. GE Healthcare 66
11.4. Carestream Health 66
11.5. Canon Australia Pty Ltd 66
11.6. Fujifilm Holdings Corporation 66
CHAPTER NO. 12 : RESEARCH METHODOLOGY 67
12.1. Research Methodology 67
12.1.1. Phase I – Secondary Research 68
12.1.2. Phase II – Data Modeling 68
Company Share Analysis Model 69
Revenue Based Modeling 69
12.1.3. Phase III – Primary Research 70
12.1.4. Research Limitations 71
Assumptions 71

List of Figures
FIG NO. 1. Australia and New Zealand Radiography Products Market, Volume (Units) & Revenue (USD Million) 2018 – 2032 19
FIG NO. 2. Porter’s Five Forces Analysis for Australia and New Zealand Radiography Products Market 27
FIG NO. 3. Company Share Analysis, 2023 28
FIG NO. 4. Company Share Analysis, 2023 29
FIG NO. 5. Company Share Analysis, 2023 29
FIG NO. 6. Company Share Analysis, 2023 29
FIG NO. 7. Australia and New Zealand Radiography Products Market – Company Volume Market Share, 2023 31
FIG NO. 8. Australia and New Zealand Radiography Products Market – Company Revenue Market Share, 2023 32
FIG NO. 9. Australia and New Zealand Radiography Products Market Revenue Share, By Type of Radiography Systems, 2023 & 2032 38
FIG NO. 10. Market Attractiveness Analysis, By Type of Radiography Systems 39
FIG NO. 11. Incremental Revenue Growth Opportunity by Type of Radiography Systems, 2024 – 2032 39
FIG NO. 12. Australia and New Zealand Radiography Products Market Revenue, By Type of Radiography Systems, 2018, 2023, 2027 & 2032 40
FIG NO. 13. Australia and New Zealand Radiography Products Market for Digital Radiography (DR), Volume (Units) & Revenue (USD Million) 2018 – 2032 41
FIG NO. 14. Australia and New Zealand Radiography Products Market for Computed Radiography (CR), Volume (Units) & Revenue (USD Million) 2018 – 2032 42
FIG NO. 15. Australia and New Zealand Radiography Products Market for Analog Radiography, Volume (Units) & Revenue (USD Million) 2018 – 2032 43
FIG NO. 16. Australia and New Zealand Radiography Products Market Revenue Share, By Application, 2023 & 2032 45
FIG NO. 17. Market Attractiveness Analysis, By Application 46
FIG NO. 18. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 46
FIG NO. 19. Australia and New Zealand Radiography Products Market Revenue, By Application, 2018, 2023, 2027 & 2032 47
FIG NO. 20. Australia and New Zealand Radiography Products Market for Medical Radiography, Volume (Units) & Revenue (USD Million) 2018 – 2032 48
FIG NO. 21. Australia and New Zealand Radiography Products Market for Industrial Radiography, Volume (Units) & Revenue (USD Million) 2018 – 2032 49
FIG NO. 22. Australia and New Zealand Radiography Products Market Revenue Share, By End-user, 2023 & 2032 51
FIG NO. 23. Market Attractiveness Analysis, By End-user 52
FIG NO. 24. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 52
FIG NO. 25. Australia and New Zealand Radiography Products Market Revenue, By End-user, 2018, 2023, 2027 & 2032 53
FIG NO. 26. Australia and New Zealand Radiography Products Market for Hospitals and Clinics, Volume (Units) & Revenue (USD Million) 2018 – 2032 54
FIG NO. 27. Australia and New Zealand Radiography Products Market for Diagnostic Centers, Volume (Units) & Revenue (USD Million) 2018 – 2032 55
FIG NO. 28. Australia and New Zealand Radiography Products Market for Industrial Manufacturing Units, Volume (Units) & Revenue (USD Million) 2018 – 2032 56
FIG NO. 29. Australia and New Zealand Radiography Products Market for Others, Volume (Units) & Revenue (USD Million) 2018 – 2032 57
FIG NO. 30. Australia and New Zealand Radiography Products Market Revenue Share, By Technology, 2023 & 2032 59
FIG NO. 31. Market Attractiveness Analysis, By Technology 60
FIG NO. 32. Incremental Revenue Growth Opportunity by Technology, 2024 – 2032 60
FIG NO. 33. Australia and New Zealand Radiography Products Market Revenue, By Technology, 2018, 2023, 2027 & 2032 61
FIG NO. 34. Australia and New Zealand Radiography Products Market for Direct Radiography, Volume (Units) & Revenue (USD Million) 2018 – 2032 62
FIG NO. 35. Australia and New Zealand Radiography Products Market for Indirect Radiography, Volume (Units) & Revenue (USD Million) 2018 – 2032 63
FIG NO. 36. Research Methodology – Detailed View 67
FIG NO. 37. Research Methodology 68

List of Tables
TABLE NO. 1. : Australia and New Zealand Radiography Products Market: Snapshot 17
TABLE NO. 2. : Drivers for the Australia and New Zealand Radiography Products Market: Impact Analysis 23
TABLE NO. 3. : Restraints for the Australia and New Zealand Radiography Products Market: Impact Analysis 25

Frequently Asked Questions:

What is the current size of the Australia and New Zealand Radiography Products Market?

The Australia and New Zealand radiography products market was valued at USD 78.61 million in 2023 and is projected to reach USD 124.38 million by 2032, representing a compound annual growth rate (CAGR) of 5.23%.

What factors are driving the growth of the Australia and New Zealand Radiography Products Market?

The growth of the Australia and New Zealand radiography products market is primarily driven by technological advancements in imaging systems, increasing prevalence of chronic diseases, rising demand for early diagnostic tools, government initiatives to improve healthcare infrastructure, and a growing aging population.

What are the key segments within the Australia and New Zealand Radiography Products Market?

The key segments within the Australia and New Zealand radiography products market include types such as Digital Radiography (DR), Computed Radiography (CR), and Analog Radiography, as well as applications including Medical Radiography and Industrial Radiography.

What are some challenges faced by the Australia and New Zealand Radiography Products Market?

Challenges faced by the Australia and New Zealand radiography products market include reimbursement challenges, high cost of advanced imaging equipment, skilled workforce shortage, stringent regulatory environment, and data security concerns.

Who are the major players in the Australia and New Zealand Radiography Products Market?

Major players in the Australia and New Zealand radiography products market include Siemens Healthineers, Koninklijke Philips NV, GE Healthcare, Carestream Health, Canon Australia Pty Ltd, and Fujifilm Holdings Corporation.

Single Use Upstream Bioprocessing Technology Market

Published:
Report ID: 41061

Viral Clearance and Testing Services Market

Published:
Report ID: 41070

Rare Kidney Diseases Market

Published:
Report ID: 41082

Single Use Bioreactors Market

Published:
Report ID: 41087

Oral Solid Dosage Manufacturing Market

Published:
Report ID: 41090

Plasmid DNA Manufacturing Market

Published:
Report ID: 41100

Nanoparticle Formulation Market

Published:
Report ID: 41106

Next Generation Drug Conjugates Market

Published:
Report ID: 41115

Lab Automation Market

Published:
Report ID: 41013

Sober Living Homes Market

Published:
Report ID: 40991

Radiopharmaceuticals Market

Published:
Report ID: 40978

Aptamers Therapeutics Technologies and Services Market

Published:
Report ID: 40945

Purchase Options

$999
Delivery Format: Excel.
$1999
Designed for the individual purchaser.
$2999
Users located at a single corporate site or regional office.
$3999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN